In collaboration with the European project SYNBEE, which strives to enhance entrepreneurship in synthetic biology across Europe, we are calling on researchers and entrepreneurs with disruptive synthetic biology solutions that address our planet’s most pressing environmental and sustainability challenges.
While many big companies believe science is key to continue innovating and expanding (as is exemplified by substantial R&D budgets), I am convinced that SynBio tools have the potential to boost all areas of innovation.
The European project will enhance the commercial potential of one of today’s most disruptive fields
eureKARE announces EonBio as the second company to be supported by its Belgium biomedical start-up studio
Ms. Lauvergeon brings an extensive background in the management of large energy corporations (most notably as CEO of Areva), finance, and government.
Innovative gene circuit technology has the potential to detect and treat cancerous and other diseased cells
Luxembourg | France | Belgium
Subscribe to our news to keep in touch
